Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.103852
Revised: March 24, 2025
Accepted: April 24, 2025
Published online: May 27, 2025
Processing time: 172 Days and 21.7 Hours
The global incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) has increased in recent years. It has already been demonstrated that exercise and weight change are associated with the occurrence of MASLD; how
To investigate the impact of weight fluctuation and physical activity intensity on the risk of MASLD prevalence.
Data from the National Health and Nutrition Examination Survey database in
Among 3183 MASLD cases, the risk of MASLD increased with age for individuals transitioning from non-obese to obese or maintaining obesity, with odds ratio (OR) changing from 8.91 (95%CI: 7.40–10.88) and 11.87 (95%CI: 9.65–14.60) at 10 years before baseline to 9.58 (95%CI: 8.08–11.37) and 12.51 (95%CI: 9.33-16.78) at 25 years. Stable obesity correlated with age-dependent MASLD prevalence escalation, whereas increased physical activity attenuated MASLD risk in this group, with an OR changing from 13.64 (95%CI: 10.59–17.57) to 6.42 (95%CI: 4.24–9.72). Further analysis of the net weight changes revealed a paradoxical risk elevation with intensified physical activity during different time periods.
The risk of MASLD increases in individuals transitioning from non-obese to obese or maintaining obesity. High-intensity physical activity is beneficial for MASLD among individuals with stable obesity.
Core Tip: The risk of metabolic dysfunction-associated steatotic liver disease (MASLD) increases with age in individuals transitioning from non-obese to obese or maintaining obesity. High-intensity physical activity is beneficial in reducing the risk of MASLD among individuals with stable obesity. Delineation of the dose-response relationship between weight fluctuation patterns and MASLD prevalence risk will facilitate the development of personalized exercise prescriptions.